Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-057711)

Filing Details

Accession Number:: 0001209191-13-057711
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-18 16:22:53
Reporting Period:: 2013-12-16

Filing Date:: 2013-12-18
Accepted Time:: 2013-12-18 16:22:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333248	Cadence Pharmaceuticals Inc	CADX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1265783	M Hazel Aker	C/O Cadence Pharmaceuticals, Inc. 12481 High Bluff Drive, Suite 200 San Diego CA 92130	Svp, Gc & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-16	13,014	$3.51	16,759	No	4	M	Direct
Common Stock	Disposition	2013-12-16	13,014	$8.76	3,745	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	stock option (right to buy)	Disposition	2013-12-16	13,014	$0.00	13,014	$3.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
109,451		2022-03-14	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2013.
25% of the 155,000 shares of common stock originally subject to the option vested on 03/14/2013, and 1/48th of the remaining number of shares of common stock subject to the option vested on the first day of each full month thereafter.
Not applicable to this transaction.